Oral clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn

Journal of the Formosan Medical Association

Volumn 102, Issue 11, 2003, Pages 801-804

  Hung, Shuo Hsun ^a   Tsai, Wen Yu ^a   Tsao, Po Nien ^a   Chou, Hung Chieh ^a   Hsieh, Wu Shiun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Case report; Clodronic acid; Fat necrosis; Hypercalcemia; Infant; Newborn

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CLODRONIC ACID; CORTISONE; CREATININE; FUROSEMIDE; GLUCOCORTICOID; HYDROCORTISONE; PARATHYROID HORMONE; SODIUM CHLORIDE; ANTIMETABOLITE;

ARTICLE; BLOOD GAS ANALYSIS; CALCIUM BLOOD LEVEL; CASE REPORT; CREATININE BLOOD LEVEL; DIET THERAPY; DOSE RESPONSE; DRUG EFFICACY; FAT NECROSIS; FEMALE; HUMAN; HYDRATION; HYPERCALCEMIA; LABORATORY TEST; NEWBORN; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL EXAMINATION; RISK FACTOR; SUBCUTANEOUS FAT DISORDER; VITAMIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTIMETABOLITES; CLODRONIC ACID; FAT NECROSIS; FEMALE; HUMANS; HYPERCALCEMIA; INFANT, NEWBORN;

EID: 1342327599     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hicks MJ, Levy ML, Alexander J, et al: Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature. Pediatr Dermatol 1993;10:271-6.
2. Lum CK, Solomon IL, Bachrach LK: Asymptomatic hycercalcemia in subcutaneous fat necrosis. Clin Pediatr 1999;38:547-50.
3. Finne PH, Sanderud J, Aksens L, et al: Hypercalcemia with increased and unregulated 1,25-dihyroxyvitamin D production in a neonate with subcutaneous fat necrosis. J Pediatr 1988;112:792-4.
4. Yasuda T, Sunami S, Ogura N, et al: Infantile hypercalcemia with subcutaneous fat necrosis. Report of a case with studies on the pathogenesis of hypercalcemia. Acta Pediatr Scand 1986;75:1042-5.
5. Thomsen RJ: Subcutaneous fat necrosis of the newborn and idiopathic hypercalcemia. Report of a case. Arch Dermatol 1980;116:1155-8.
6. Alan R, Scott R: Etidronate therapy for hypercalcemia in subcutaneous fat necrosis of the newborn. J Pediatr 1999;134:349-51.
7. Khan N, Licata A, Rogers D: Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach. Clin Pediatr 2001;40:217-9.
8. Todd PW, Gillian M: Subcutaneous fat necrosis of the newborn following hypothermia and complicated by pain and hypercalcaemia. Australas J Dermatol 2001;42:207-10.
9. Sharata H, Postellon DC, Hashimoto K: Subcutaneous fat necrosis, hypercalcemia, and prostaglandin E. Pediatr Dermatol 1995;12:43-7.
10. Burden AD, Krafchik BR: Subcutaneous fat necrosis of the newborn: a review of 11 cases. Pediatr Dermatol 1999;16:384-7.
11. Gu LL, Daneman A, Binet A, et al: Nephrocalcinosis and nephrolithiasis due to subcutaneous fat necrosis with hypercalcemia in two full-term asphyxiated neonates: sonographic findings. Pediatr Radiol 1995;25:142-4.
12. Kruse K, Irle U, Uhlig R: Elevated 1,25-dihydroxyvitamin D serum concentrations in infants with subcutaneous fat necrosis. J Pediatr 1993;122:460-3.
13. Cook JS, Stone MS, Hansen JR: Hypercalcemia in association with subcutaneous fat necrosis of the newborn: studies of calcium-regulating hormones. Pediatrics 1992;90:93-6.
14. Gkonos PJ, London R, Hendler ED: Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med 1984;311:1683-5.
15. 3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 1987;65:1201-9.
16. Hanson DA, Weis MA, Bollen AM, et al: A specific immunoassay for monitoring human bone resorption: quantitation of type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
17. Bijvoet OL, Frijlink WM, Jie K, et al: APD in Paget's disease of bone. Role of the mononuclear phagocyte system? Arthritis Rheum 1980;23:1193-204.